These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5597568)

  • 1. [On the action of a new compound, adrenochrome semicarbazone sulfonic ester, in the treatment of hemoptysis].
    Fossati C
    G Ital Mal Torace; 1967; 21(4):211-6. PubMed ID: 5597568
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of the sulphonic ester of sodium adrenochrome semicarbazone and of adrenochrome semicarbazone on the cardiovascular system and intestinal musculature].
    Marmo E; Caputi AP; Cataldi S
    Minerva Cardioangiol; 1972 Jun; 20(6):303-17. PubMed ID: 5040406
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenochrome monosemicarbazone sodium salicylate complex and blood loss. Report of negative results.
    Thompson WB; Brock JA
    Obstet Gynecol; 1970 May; 35(5):797-9. PubMed ID: 4909683
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of the sulfonic ester of adrenochrome semicarbazone in the therapy of phlebopathies and obliterating arteriosclerotic arteriopathies of the lower extremities].
    Seghezzi R; Pedroni G; Ercoli A
    Chir Ital; 1967; 19():Suppl 2:349+. PubMed ID: 5190607
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adrenochrome semicarbazone sulfonic ester and capillary fragility].
    Cristofolini M; Pedrazzoli M
    Clin Ter; 1969 Mar; 48(6):557-62. PubMed ID: 5404654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Histomorphological findings on the palatine tonsil after administration of adrenochrome semicarbazone sulfonic ester].
    Galletti C; Antonuccio C; Germanà G; Passantino G
    Boll Mal Orecch Gola Naso; 1969; 87(3):220-30. PubMed ID: 5381640
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of a new hemostatic in surgery. Emex (sulfinic ester of adrenochrome semicarbazone)].
    Roten G
    Praxis; 1969 Jan; 58(1):22-4. PubMed ID: 5818513
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
    Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of destructive pulmonary tuberculosis with the use of endobronchial methods of administration of antitubercular agents].
    Rzhavskov IuV
    Probl Tuberk; 1966; 44(4):16-21. PubMed ID: 5997391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Certain aspects of new combinations of drugs for the treatment of drug-resistant tuberculosis].
    Jancík E; Novák M; Jancíková M; Tousek J; Krátký J; Feitová S; Zelenka M
    Bull Int Union Tuberc; 1968 Dec; 41():188-91. PubMed ID: 5710247
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of intensified chemotherapeutic regimens in the re-treatment of pulmonary tuberculosis].
    Maekawa N
    Kekkaku; 1968 Dec; 43(12):523-5. PubMed ID: 5716119
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of pulmonary tuberculosis with intravenous injections of tuberculostatic preparations].
    Pilipchuk NS; Kolesnikova ZhIa
    Vrach Delo; 1967 Apr; 4():41-5. PubMed ID: 5612195
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy protocols for the treatment of chronic destructive pulmonary tuberculosis].
    Korotaev GA
    Probl Tuberk; 1982 Oct; (10):34-9. PubMed ID: 7178101
    [No Abstract]   [Full Text] [Related]  

  • 14. [New aspects of short-term chemotherapy of tuberculosis].
    Zierski M; Snider DE
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():473-6. PubMed ID: 6359126
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intermittent treatment of pulmonary tuberculosis--controlled clinical trials in Czechoslovakia].
    Víznerová A
    Cas Lek Cesk; 1984 Feb; 123(6):165-9. PubMed ID: 6365321
    [No Abstract]   [Full Text] [Related]  

  • 16. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents].
    Veen J
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on the re-treatment of relapsed cases of pulmonary tuberculosis].
    Yamamoto M
    Kekkaku; 1968 Dec; 43(12):515-7. PubMed ID: 5716115
    [No Abstract]   [Full Text] [Related]  

  • 18. Changing treatment of tuberculosis.
    Grzybowski S; Hershfield E
    Can Med Assoc J; 1982 Mar; 126(5):457-8. PubMed ID: 7066799
    [No Abstract]   [Full Text] [Related]  

  • 19. [New experiences with 4-4' diisomayloxythiocarbanilide (D.A.T.C.) in association with other antitubercular drugs in chronic pulmonary tuberculosis].
    Frati HI
    Rev Sanid Milit Argent; 1967; 66(1):71-4. PubMed ID: 5629062
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical uses of the sulfonic ester of adrenochrome semicarbazone (EMEX) in otorhinolaryngoiatric practice].
    Russo C
    Ann Laringol Otol Rinol Faringol; 1966; 65(4):499-514. PubMed ID: 6014493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.